Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort study

Catriona R Mayland1,2, Michelle Collinson3, Sam H Ahmedzai4

  • 1Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. c.r.mayland@sheffield.ac.uk.

BMC Palliative Care
|June 13, 2026
PubMed
Summary

Malignant mesothelioma patients with moderate to severe pain had poorer quality of life and did not receive strong opioids. Early identification of high-risk patients is crucial for timely pain management strategies.